Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UMBRALISIB for Lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where UMBRALISIB was used for Lymphoma.

Most Reported Side Effects for UMBRALISIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 47 16.0% 2 5
Nausea 36 12.3% 1 5
Disease progression 30 10.2% 2 3
Fatigue 30 10.2% 1 0
Covid-19 16 5.5% 3 13
Nervous system disorder 15 5.1% 0 0
Death 14 4.8% 14 4
Asthenia 13 4.4% 1 2
Off label use 13 4.4% 1 0
Product dose omission issue 12 4.1% 0 3
Anaemia 11 3.8% 0 0
Decreased appetite 11 3.8% 1 2
Pyrexia 11 3.8% 0 0
Dizziness 10 3.4% 0 3
Drug ineffective 10 3.4% 0 0

Other Indications for UMBRALISIB

Chronic lymphocytic leukaemia (66) Non-hodgkin's lymphoma (50) Follicular lymphoma (48) Product used for unknown indication (42) Diffuse large b-cell lymphoma (20) Marginal zone lymphoma (20) B-cell lymphoma (18)

Other Drugs Used for Lymphoma

RITUXIMAB (3,142) CYCLOPHOSPHAMIDE (1,729) VINCRISTINE (1,452) LENALIDOMIDE (1,427) DOXORUBICIN (1,420) ETOPOSIDE (915) IBRUTINIB (896) PREDNISONE (672) METHOTREXATE (647) CYTARABINE (645)

Related Pages

UMBRALISIB Full Profile All Lymphoma Drugs UMBRALISIB Demographics UMBRALISIB Timeline